Chevy Chase Trust Holdings, Inc. Abb Vie Inc. Transaction History
Chevy Chase Trust Holdings, Inc.
- $35.7 Billion
- Q3 2025
A detailed history of Chevy Chase Trust Holdings, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Chevy Chase Trust Holdings, Inc. holds 930,562 shares of ABBV stock, worth $218 Million. This represents 0.6% of its overall portfolio holdings.
Number of Shares
930,562
Previous 962,268
3.29%
Holding current value
$218 Million
Previous $179 Million
20.63%
% of portfolio
0.6%
Previous 0.53%
Shares
34 transactions
Others Institutions Holding ABBV
# of Institutions
4,491Shares Held
1.28BCall Options Held
16.9MPut Options Held
15.2M-
Vanguard Group Inc Valley Forge, PA178MShares$41.6 Billion0.64% of portfolio
-
Black Rock Inc. New York, NY136MShares$31.9 Billion0.54% of portfolio
-
State Street Corp Boston, MA79.8MShares$18.7 Billion0.66% of portfolio
-
Jpmorgan Chase & CO New York, NY56.5MShares$13.2 Billion0.86% of portfolio
-
Morgan Stanley New York, NY41.7MShares$9.75 Billion0.61% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $414B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...